Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs
Advanced Healthcare Materials · 2023-12 · 12 (31)
DOI: 10.1002/adhm.202301764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.08.2023. Verfasst von JiHyeon Hwang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Among multiple approaches to combating antimicrobial resistance, a combination therapy of existing antibiotics with bacterial membrane‐perturbing agents is promising. A viable platform of metallopolymers as adjuvants in combination with traditional antibiotics is reported in this work to combat both planktonic and stationary cells of Gram‐negative superbugs and their biofilms. Antibacterial efficacy, toxicity, antibiofilm activity, bacterial resistance propensity, and mechanisms of action of metallopolymer‐antibiotic combinations are investigated. These metallopolymers exhibit 4‐16‐fold potentiation of antibiotics against Gram‐negative bacteria with negligible toxicity toward mammalian cells. More importantly, the lead combinations (polymer‐ceftazidime and polymer‐rifampicin) eradicate preformed biofilms of MDR E. coli and P. aeruginosa , respectively. Further, β‐lactamase inhibition, outer membrane permeabilization, and membrane depolarization demonstrate synergy of these adjuvants with different antibiotics. Moreover, the membrane‐active metallopolymers enable the antibiotics to circumvent bacterial resistance development. Altogether, the results indicate that such non‐antibiotic adjuvants bear the promise to revitalize the efficacy of existing antibiotics to tackle Gram‐negative bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA.
- Department of Chemistry, University of South Florida, Tampa, FL, 33620, USA.
- Department of Pathology, Microbiology and Immunology, University of South Carolina, School of Medicine, Columbia, SC, 29209, USA.
- Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, 48824, USA.
ORCID-Profile: JiHyeon Hwang, Chuanbing Tang
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Hwang, J., Barman, S., Gao, R., Yang, X., O'Malley, A., Nagarkatti, P., Nagarkatti, M., Chruszcz, M., & Tang, C. (2023). Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs. Advanced Healthcare Materials, 12(31). https://doi.org/10.1002/adhm.202301764
Vancouver
Hwang J, Barman S, Gao R, Yang X, O'Malley A, Nagarkatti P, et al. Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs. Advanced Healthcare Materials. 2023;12(31). doi:10.1002/adhm.202301764
BibTeX
@article{Hwang2023,
author = {Hwang, JiHyeon and Barman, Swagatam and Gao, Ruixuan and Yang, Xiaoming and O'Malley, Andrea and Nagarkatti, Prakash and Nagarkatti, Mitzi and Chruszcz, Maksymilian and Tang, Chuanbing},
title = {Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {31},
doi = {10.1002/adhm.202301764}
}
EUVIMED